AI assistant
Sending…
Cigna Group — Director's Dealing 2021
Feb 27, 2021
29918_dirs_2021-02-26_0f16446c-c785-446c-9ec7-3ea2488e417e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2021-02-24
Reporting Person: Miller Steven B (EVP, Chief Clinical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-24 | Common Stock, $.01 Par Value | A | 1287.0000 | $0.0000 | Acquired | 27546.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-24 | Employee Stock Option (Right to Buy) | $213.8000 | A | 6134.0000 | Acquired | 2031-02-24 | Common Stock, $.01 Par Value (6134.0000) | Direct |
Footnotes
F1: These restricted shares vest in three equal annual installments beginning March 1, 2022.
F2: This option vests in three equal annual installments beginning March 1, 2022.
More from Cigna Group
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4